Skip to main content

Table 2 Comparison of clinical characteristics according to the required duration of endoscopic vacuum-assisted closure (EVAC) treatment

From: Endoscopic vacuum therapy for postoperative esophageal leak

Variables <  21 days
(n = 12)
≥ 21 days
(n = 8)
p-value
Patients
Male 12 (100.0) 8 (100.0)  
Age, years 67 (57–76) 63 (53–77) 0.34
CCI point 0.16
 0 10 (83.3) 4 (50.0)  
 1–3 2 (16.7) 4 (50.0)  
Neoadjuvant treatment 0.02
  No 9 (75.0) 1 (12.5)  
  Yes 3 (25.0) 7 (87.5)  
Operation 0.18
 Ivor-Lewis operation 4 (33.3) 3 (37.5)  
 3-field lymph node dissection 3 (25.0) 5 (62.5)  
 McKeown operation 4 (33.3) 0  
 Transhiatal esophagectomy 1 (8.3) 0  
Level of anastomosis 0.16
 Intrathoracic anastomosis 6 (50.0) 7 (87.5)  
 Cervical anastomosis 6 (50.0) 1 (12.5)  
Anastomotic leak
 Time to diagnosis, days 13 (5–35) 13 (5–24) 0.62
 Fistula size, cm 1.0 (0.5–3.0) 2.0 (0.8–3.0) 0.05
 Mucosal ischemia on EGD 9 (75.0) 7 (87.5) 0.62
EVAC treatment
 Time to treatment, days 3 (0–24) 3 (0–9) 0.52
 Duration of EVAC, days 8 (4–18) 26 (21–56) 0.00
 Interventions 3 (2–6) 8 (5–12) < 0.01
 Treatment failure 0 1 (12.5) 0.40
Hospital stay, days 45 (19–90) 59 (29–84) 0.08
Mortality 0 1 (12.5) 0.40
  1. CCI Charlson comorbidity index, EGD esophagoduodenoscopy
  2. Data are shown as the median with range or number (%) of patients